286 related articles for article (PubMed ID: 28556946)
1. Dexmedetomidine protects mice against myocardium ischaemic/reperfusion injury by activating an AMPK/PI3K/Akt/eNOS pathway.
Sun Y; Jiang C; Jiang J; Qiu L
Clin Exp Pharmacol Physiol; 2017 Sep; 44(9):946-953. PubMed ID: 28556946
[TBL] [Abstract][Full Text] [Related]
2. Effects of dexmedetomidine postconditioning on myocardial ischemia and the role of the PI3K/Akt-dependent signaling pathway in reperfusion injury.
Cheng XY; Gu XY; Gao Q; Zong QF; Li XH; Zhang Y
Mol Med Rep; 2016 Jul; 14(1):797-803. PubMed ID: 27221008
[TBL] [Abstract][Full Text] [Related]
3. Effects of dexmedetomidine on myocardial ischemia-reperfusion injury through PI3K-Akt-mTOR signaling pathway.
Zhang J; Jiang H; Liu DH; Wang GN
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6736-6743. PubMed ID: 31378917
[TBL] [Abstract][Full Text] [Related]
4. Over-expression of HSPA12B protects mice against myocardium ischemic/reperfusion injury through a PPARγ-dependent PI3K/Akt/eNOS pathway.
Sun Y; Ye L; Jiang C; Jiang J; Hong H; Qiu L
Am J Transl Res; 2015; 7(12):2724-37. PubMed ID: 26885270
[TBL] [Abstract][Full Text] [Related]
5. The protective effect of dexmedetomidine on LPS-induced acute lung injury through the HMGB1-mediated TLR4/NF-κB and PI3K/Akt/mTOR pathways.
Meng L; Li L; Lu S; Li K; Su Z; Wang Y; Fan X; Li X; Zhao G
Mol Immunol; 2018 Feb; 94():7-17. PubMed ID: 29241031
[TBL] [Abstract][Full Text] [Related]
6. Dexmedetomidine protects the heart against ischemia-reperfusion injury by an endothelial eNOS/NO dependent mechanism.
Riquelme JA; Westermeier F; Hall AR; Vicencio JM; Pedrozo Z; Ibacache M; Fuenzalida B; Sobrevia L; Davidson SM; Yellon DM; Sánchez G; Lavandero S
Pharmacol Res; 2016 Jan; 103():318-27. PubMed ID: 26607864
[TBL] [Abstract][Full Text] [Related]
7. Effects of Dexmedetomidine Postconditioning on Myocardial Ischemia/Reperfusion Injury in Diabetic Rats: Role of the PI3K/Akt-Dependent Signaling Pathway.
Cheng X; Hu J; Wang Y; Ye H; Li X; Gao Q; Li Z
J Diabetes Res; 2018; 2018():3071959. PubMed ID: 30402501
[TBL] [Abstract][Full Text] [Related]
8. Adiponectin protects against myocardial ischaemia-reperfusion injury via AMP-activated protein kinase, Akt, and nitric oxide.
Gonon AT; Widegren U; Bulhak A; Salehzadeh F; Persson J; Sjöquist PO; Pernow J
Cardiovasc Res; 2008 Apr; 78(1):116-22. PubMed ID: 18222959
[TBL] [Abstract][Full Text] [Related]
9. Dexmedetomidine pretreatment protects the heart against apoptosis in ischemia/reperfusion injury in diabetic rats by activating PI3K/Akt signaling in vivo and in vitro.
Chang JH; Jin MM; Liu JT
Biomed Pharmacother; 2020 Jul; 127():110188. PubMed ID: 32407987
[TBL] [Abstract][Full Text] [Related]
10. Role of carvacrol in cardioprotection against myocardial ischemia/reperfusion injury in rats through activation of MAPK/ERK and Akt/eNOS signaling pathways.
Chen Y; Ba L; Huang W; Liu Y; Pan H; Mingyao E; Shi P; Wang Y; Li S; Qi H; Sun H; Cao Y
Eur J Pharmacol; 2017 Feb; 796():90-100. PubMed ID: 27916558
[TBL] [Abstract][Full Text] [Related]
11. Dexmedetomidine alleviates lung ischemia-reperfusion injury in rats by activating PI3K/Akt pathway.
Liang S; Wang Y; Liu Y
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):370-377. PubMed ID: 30657579
[TBL] [Abstract][Full Text] [Related]
12. Protective effect of ligustrazine against myocardial ischaemia reperfusion in rats: the role of endothelial nitric oxide synthase.
Lv L; Jiang SS; Xu J; Gong JB; Cheng Y
Clin Exp Pharmacol Physiol; 2012 Jan; 39(1):20-7. PubMed ID: 22004361
[TBL] [Abstract][Full Text] [Related]
13. Cardioprotection of hydralazine against myocardial ischemia/reperfusion injury in rats.
Li C; Su Z; Ge L; Chen Y; Chen X; Li Y
Eur J Pharmacol; 2020 Feb; 869():172850. PubMed ID: 31830459
[TBL] [Abstract][Full Text] [Related]
14. Dexmedetomidine attenuates renal ischemia-reperfusion injury through activating PI3K/Akt-eNOS signaling via α
Shan X; Zhang J; Wei X; Tao W; Peng K; Liu H; Wang Y; Liu H; Meng X; Ji F
FASEB J; 2022 Nov; 36(11):e22608. PubMed ID: 36250975
[TBL] [Abstract][Full Text] [Related]
15. Salidroside improves endothelial function and alleviates atherosclerosis by activating a mitochondria-related AMPK/PI3K/Akt/eNOS pathway.
Xing SS; Yang XY; Zheng T; Li WJ; Wu D; Chi JY; Bian F; Bai XL; Wu GJ; Zhang YZ; Zhang CT; Zhang YH; Li YS; Jin S
Vascul Pharmacol; 2015 Sep; 72():141-52. PubMed ID: 26187353
[TBL] [Abstract][Full Text] [Related]
16. Ischaemic preconditioning-induced serum exosomes protect against myocardial ischaemia/reperfusion injury in rats by activating the PI3K/AKT signalling pathway.
Zhang J; Zhang X
Cell Biochem Funct; 2021 Mar; 39(2):287-295. PubMed ID: 32767595
[TBL] [Abstract][Full Text] [Related]
17. Heart protective effects and mechanism of quercetin preconditioning on anti-myocardial ischemia reperfusion (IR) injuries in rats.
Liu H; Guo X; Chu Y; Lu S
Gene; 2014 Jul; 545(1):149-55. PubMed ID: 24769323
[TBL] [Abstract][Full Text] [Related]
18. Hydromorphine postconditioning protects isolated rat heart against ischemia-reperfusion injury via activating P13K/Akt/eNOS signaling.
Liu Q; Li Z; Liu Y; Xiao Q; Peng X; Chen Q; Deng R; Gao Z; Yu F; Zhang Y
Cardiovasc Ther; 2018 Dec; 36(6):e12481. PubMed ID: 30597772
[TBL] [Abstract][Full Text] [Related]
19. Hydrogen‑rich solution against myocardial injury and aquaporin expression via the PI3K/Akt signaling pathway during cardiopulmonary bypass in rats.
Song D; Liu X; Diao Y; Sun Y; Gao G; Zhang T; Chen K; Pei L
Mol Med Rep; 2018 Aug; 18(2):1925-1938. PubMed ID: 29956781
[TBL] [Abstract][Full Text] [Related]
20. Dexmedetomidine alleviates hepatic ischaemia-reperfusion injury via the PI3K/AKT/Nrf2-NLRP3 pathway.
Wu Y; Qiu G; Zhang H; Zhu L; Cheng G; Wang Y; Li Y; Wu W
J Cell Mol Med; 2021 Nov; 25(21):9983-9994. PubMed ID: 34664412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
